Skip to main content
. Author manuscript; available in PMC: 2020 Feb 15.
Published in final edited form as: Clin Cancer Res. 2018 Jul 27;25(4):1233–1238. doi: 10.1158/1078-0432.CCR-18-0762

Figure 4: Effect of CTLA-4 blockade on CD68+ cells.

Figure 4:

Stage-matched untreated and Ipi-treated (N=16) metastatic melanoma samples were analyzed by IHC for the presence of CD68+ cells. Each plot shows mean with SD, and each symbol represents an individual patient. Statistical significance is defined as P < 0.05.